LICENSE AGREEMENTLicense Agreement • May 10th, 2019 • Puma Biotechnology, Inc. • Pharmaceutical preparations
THIS LICENSE AGREEMENT (“Agreement”) dated as of March 29th, 2019 (“Effective Date”) is entered into between Puma Biotechnology, Inc., a corporation organized and existing under the laws of Delaware with its principal place of business at 10880 Wilshire Blvd, Los Angeles, CA 90024 (“Licensor”) and Pierre Fabre Medicament SAS, a company duly organized and existing under the laws of France, having offices and principal place of business at 45, Place Abel Gance 92100 Boulogne Billancourt, France (“Licensee”).
